ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846
Reader Mode
-A A +A

The Global Relevance of India's Pharmaceutical Patent Laws

The recent decision in the Novartis Glivec case continues a long-established tradition of India contesting a Northern agenda on patent laws. This key global role, arising from the exceptional combination of a vibrant domestic pharmaceutical industry with civil society awareness of the public health implications of patents, has been accentuated by recent developments and has continued relevance for the global South.

Subscribers please login to access full text of the article.

New 3 Month Subscription
to Digital Archives at

649for India

$20for overseas users

Get instant access to the complete EPW archives

Subscribe now


(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top